Literature DB >> 19878660

Methamphetamine directly accelerates beating rate in cardiomyocytes by increasing Ca(2+) entry via L-type Ca(2+) channel.

Kana Sugimoto1, Ko Okamura, Hidekazu Tanaka, Seiji Takashima, Hiroshi Ochi, Takuma Yamamoto, Ryoji Matoba.   

Abstract

Methamphetamine induces several cardiac dysfunctions, which leads to arrhythmia, cardiac failure and sudden cardiac death. Although these cardiac alterations elicited by methamphetamine were thought to be due to an indirect action of methamphetamine, namely, an excessive catecholamine release from synaptic terminals, while it seems likely that methamphetamine directly modulates the functioning of cardiomyocytes independent of neurotransmitters. However, the direct effects of methamphetamine on cardiomyocytes are still not clear. We show that methamphetamine directly accelerates the beating rate and alters Ca(2+) oscillation pattern in cultured neonatal rat cardiomyocytes. Adrenergic receptor antagonists did not block the methamphetamine-induced alterations in cardiomyocytes. Treatment with a ryanodine receptor type 2 inhibitor and a sarcoplasmic reticulum Ca(2+)-ATPase inhibitor did not affect these responses, either. In contrast, the L-type Ca(2+) channel inhibitor nifedipine eradicated these responses. Furthermore, methamphetamine elevated the internal free Ca(2+) concentration in HEK-293T cells stably transfected with the L-type Ca(2+) channel alpha1C subunit. In neonatal rat cardiomyocytes, methamphetamine accelerates beating rate and alters Ca(2+) oscillation pattern by increasing Ca(2+) entry via the L-type Ca(2+) channels independent of any neurotransmitters.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878660     DOI: 10.1016/j.bbrc.2009.10.124

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  A cell-based biosensor for real-time detection of cardiotoxicity using lensfree imaging.

Authors:  Sang Bok Kim; Hojae Bae; Jae Min Cha; Sang Jun Moon; Mehmet R Dokmeci; Donald M Cropek; Ali Khademhosseini
Journal:  Lab Chip       Date:  2011-04-11       Impact factor: 6.799

Review 2.  Methamphetamine Use and Cardiovascular Disease.

Authors:  Christopher G Kevil; Nicholas E Goeders; Matthew D Woolard; Md Shenuarin Bhuiyan; Paari Dominic; Gopi K Kolluru; Connie L Arnold; James G Traylor; A Wayne Orr
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-21       Impact factor: 8.311

Review 3.  Stimulant Drugs of Abuse and Cardiac Arrhythmias.

Authors:  Paari Dominic; Javaria Ahmad; Hajra Awwab; Md Shenuarin Bhuiyan; Christopher G Kevil; Nicholas E Goeders; Kevin S Murnane; James C Patterson; Kristin E Sandau; Rakesh Gopinathannair; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-12-28

4.  Methamphetamine increases dopamine release in the nucleus accumbens through calcium-dependent processes.

Authors:  Jordan T Yorgason; David M Hedges; J Daniel Obray; Eun Young Jang; Kyle B Bills; Mark Woodbury; Ben Williams; Mandy J Parsons; Marilou A Andres; Scott C Steffensen
Journal:  Psychopharmacology (Berl)       Date:  2020-01-21       Impact factor: 4.530

5.  The effect of methamphetamine on an animal model of erectile function.

Authors:  M T Tar; L R Martinez; J D Nosanchuk; K P Davies
Journal:  Andrology       Date:  2014-04-03       Impact factor: 3.842

6.  Impairment of brain endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction.

Authors:  P M Abdul Muneer; Saleena Alikunju; Adam M Szlachetka; L Charles Murrin; James Haorah
Journal:  Mol Neurodegener       Date:  2011-03-22       Impact factor: 14.195

7.  Sex-dependent right ventricular hypertrophic gene changes after methamphetamine treatment in mice.

Authors:  Hicham Labazi; Margaret Nilsen; Margaret R MacLean
Journal:  Eur J Pharmacol       Date:  2021-03-28       Impact factor: 4.432

Review 8.  Toxic Effects of Methamphetamine on Perivascular Health: Co-morbid Effects of Stress and Alcohol Use Disorders.

Authors:  Eric A Rodriguez; Bryan K Yamamoto
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.